Influenza A virus H5N1 vaccine - Denka SeikenAlternative Names: A-04-01D
Latest Information Update: 25 Nov 2015
At a glance
- Originator Denka Seiken
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H5N1 subtype
Most Recent Events
- 25 Nov 2015 No recent reports on development identified - Phase-II/III for Influenza-A virus H5N1 subtype (Prevention, In adults) in Japan (IM)